Meeran, Karim

A role for glucagon-like peptide-1 in the central regulation of feeding

Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature

Regulation of Appetite and ObesityNeuropeptides and Animal Physiology

Cited by 1,950

Subcutaneous Oxyntomodulin Reduces Body Weight in Overweight and Obese Subjects

Wynne, K., Park, A. J., Small, C. J., Patterson, M., Ellis, S. M., Murphy, K. G., Wren, A. M., Frost, G. S., Meeran, K., Ghatei, M. A., et al. (2005) · Diabetes

Regulation of Appetite and ObesityPharmacology and Obesity Treatment

Cited by 435

Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial

Wynne, K., Park, A. J., Small, C. J., Meeran, K., Ghatei, M. A., Frost, G. S., & Bloom, S. R. (2006) · International Journal of Obesity

Regulation of Appetite and ObesityPharmacology and Obesity Treatment

Cited by 363

Repeated Intracerebroventricular Administration of Glucagon-Like Peptide-1-(7–36) Amide or Exendin-(9–39) Alters Body Weight in the Rat**This work was supported by the United Kingdom Medical Research Council.

Meeran, K., O’Shea, D., Edwards, C. M. B., Turton, M. D., Heath, M. M., Gunn, I., Abusnana, S., Rossi, M., Small, C. J., Goldstone, A. P., et al. (1999) · Endocrinology

Regulation of Appetite and ObesityDiabetes Treatment and Management

Cited by 303

Effectiveness of metyrapone in treating Cushing's syndrome: a retrospective multicenter study in 195 patients

Daniel, E., Aylwin, S., Mustafa, O., Ball, S., Munir, A., Boelaert, K., Chortis, V., Cuthbertson, D. J., Daousi, C., Rajeev, S. P., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism

Pituitary Gland Disorders and TreatmentsAdrenal Hormones and Disorders

Cited by 231

Coinfusion of low-dose GLP-1 and glucagon in man results in a reduction in food intake

Cegla, J., Troke, R. C., Jones, B., Tharakan, G., Kenkre, J., McCullough, K. A., Lim, C. T., Parvizi, N., Hussein, M., Chambers, E. S., et al. (2014) · Diabetes

Regulation of Appetite and ObesityDiabetes Treatment and Management

Cited by 159

Is a 0900-h serum cortisol useful prior to a short Synacthen test in outpatient assessment?

le Roux, C., Meeran, K., & Alaghband-Zadeh, J. (2002) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine

Adrenal Hormones and DisordersStress Responses and Cortisol

Cited by 77

Late-night salivary cortisol and cortisone should be the initial screening test for cushing's syndrome

Mohamed, R. S., Abuelgasim, B., Barker, S., Prabhudev, H., Martin, N. M., Meeran, K., Williams, E. L., Darch, S., Matthew, W., Tan, T., et al. (2022) · Endocrine Connections

Pituitary Gland Disorders and TreatmentsAdrenal Hormones and Disorders

Cited by 18